Literature DB >> 17499657

Prehospital use of analgesics at home or en route to the hospital in children with extremity injuries.

Alex L Rogovik1, Ran D Goldman.   

Abstract

PURPOSE: The purpose of the study was to document prehospital analgesia (PA) for children with extremity injuries at home or en route to the hospital, as assessed by research personnel at the pediatric emergency department.
METHODS: Two parallel groups of patients with fractures or soft-tissue injuries (STIs) were chosen for this prospective observational study. Patients 3 to 18 years of age with a limb or clavicle injury were enrolled. Parents or children were interviewed, pain assessed, and data from the emergency department charts collected.
RESULTS: A total of 310 patients were recruited; their mean age was 10.2 years, and 62% had fractures. The median pain score was 4.0, with no significant difference between fractures and STI. Of the patients, 78% had PA, 73% received first aid (icing, immobilization), and 37% had medication, mostly acetaminophen and ibuprofen. Children with fractures and STI received PA at a similar rate; however, the time to first aid was shorter in those with fractures.
CONCLUSION: Most patients with moderate or severe pain did not receive prehospital pain medication. Parental education and moderate over-the-counter analgesics are needed for better pain relief.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17499657     DOI: 10.1016/j.ajem.2006.11.021

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  2 in total

1.  Acetaminophen in children: an old drug with new warnings.

Authors:  Ran D Goldman
Journal:  Can Fam Physician       Date:  2013-10       Impact factor: 3.275

Review 2.  How Safe Are Common Analgesics for the Treatment of Acute Pain for Children? A Systematic Review.

Authors:  Lisa Hartling; Samina Ali; Donna M Dryden; Pritam Chordiya; David W Johnson; Amy C Plint; Antonia Stang; Patrick J McGrath; Amy L Drendel
Journal:  Pain Res Manag       Date:  2016-12-18       Impact factor: 3.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.